| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 12 | +0.00% | +13.16% | -3.16% | +16.32% | +12.44% | — |
| 14d | 12 | +75.00% | +13.76% | -3.83% | +17.59% | +0.79% | — |
| 30d | 12 | +0.00% | +25.42% | +1.02% | +24.40% | +11.61% | — |
| 60d | 12 | +0.00% | +13.16% | +4.25% | +8.92% | +8.92% | — |
| 90d | 12 | +0.00% | +27.30% | +9.21% | +20.24% | +20.24% | — |
| 180d | 12(3 pending) | +100.00% | -15.64% | +16.95% | -32.59% | -32.59% | — |
| 1y | 12(3 pending) | +100.00% | -55.41% | +11.82% | -67.22% | -67.22% | — |
| 2y | 12(12 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| SLNO SOLENO THERAPEUTICS INC | SALE Chief Commercial Officer | 32,800 | — | — | 0 | May 18, 2026 | May 18, 2026 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Chief Commercial Officer | 91,000 | — | — | 0 | May 18, 2026 | May 18, 2026 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Chief Commercial Officer | 64,507 | — | — | 0 | May 18, 2026 | May 18, 2026 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Chief Commercial Officer | 29,200 | — | — | 0 | May 18, 2026 | May 18, 2026 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Chief Commercial Officer | 558 | $31.72 | $17.7K | 64,507 | Mar 27, 2026 | Mar 31, 2026 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Chief Commercial Officer | 4,864 | $30.04 | $146.1K | 67,165 | Mar 27, 2026 | Mar 31, 2026 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Chief Commercial Officer | 2,100 | $31.04 | $65.2K | 65,065 | Mar 27, 2026 | Mar 31, 2026 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | PURCHASEGRANT Stock grant | 28,600 | — | — | 72,029 | Jan 21, 2026 | Jan 23, 2026 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | PURCHASEGRANT Stock grant | 32,800 | — | — | 32,800 | Jan 21, 2026 | Jan 23, 2026 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Chief Commercial Officer | 1,922 | $49.95 | $96.0K | 43,429 | Dec 15, 2025 | Dec 17, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Chief Commercial Officer | 225 | $71.74 | $16.1K | 45,385 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Chief Commercial Officer | 34 | $72.64 | $2.5K | 45,351 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Chief Commercial Officer | 37,000 | — | — | 91,000 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Chief Commercial Officer | 37,000 | $67.04 | $2.48M | 45,351 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Chief Commercial Officer | 1,087 | $66.79 | $72.6K | 51,845 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | PURCHASE Chief Commercial Officer | 37,000 | $46.31 | $1.71M | 82,351 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Chief Commercial Officer | 668 | $65.97 | $44.1K | 52,932 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Chief Commercial Officer | 2,599 | $68.79 | $178.8K | 47,270 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Chief Commercial Officer | 1,505 | $69.84 | $105.1K | 45,765 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Chief Commercial Officer | 155 | $70.73 | $11.0K | 45,610 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Chief Commercial Officer | 1,976 | $67.70 | $133.8K | 49,869 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | PURCHASEGRANT Stock grant | 29,200 | — | — | 29,200 | Jan 21, 2025 | Jan 23, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | PURCHASEGRANT Stock grant | 13,600 | — | — | 53,600 | Jan 21, 2025 | Jan 23, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Jul 17, 2024 | Jul 19, 2024 ↗ | View → |